influenza self- amplifying ribonucleic acid vaccine (PF-07852352) / Pfizer - LARVOL DELTA

A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza (clinicaltrials.gov) - P1 | N=442 | Completed | Sponsor: Pfizer | Active, not recruiting ➔ Completed

Trial completion • Infectious Disease • Influenza • Respiratory Diseases

A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza (clinicaltrials.gov) - P1 | N=448 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting

Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases

A Study to Evaluate Self-Amplifying Ribonucleic Acid (RNA) Vaccine Preparations Against Influenza (clinicaltrials.gov) - P1 | N=468 | Recruiting | Sponsor: Pfizer | Trial completion date: Apr 2023 ➔ Jul 2023 | Trial primary completion date: Apr 2023 ➔ Jul 2023

Trial completion date • Trial primary completion date • Infectious Disease • Influenza • Respiratory Diseases

A Study to Evaluate Self-Amplifying Ribonucleic Acid (RNA) Vaccine Preparations Against Influenza (clinicaltrials.gov) - P1 | N=468 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease • Respiratory Diseases